Rare diseases
Investigational molecules
Locations
Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
AustriaStudy of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy
CzechiaStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
BulgariaLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
AustriaStudy of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus
BulgariaStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
BulgariaLong-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment
CzechiaStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
BelgiumStudy of early versus late risankizumab treatment to evaluate immune cell response in patients with moderate to severe psoriasis
SpainStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
AustriaStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
BelgiumStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
